Search results
Pfizer (PFE) Phase III DMD Gene Therapy Study Misses Goal
Zacks via Yahoo Finance· 5 days agoPfizer's (PFE) phase III study, CIFFREO, fails to show improvement in motor function in ambulatory...
Novavax Seeks FDA Nod for Updated COVID-19 Vaccine - Novavax (NASDAQ:NVAX), Moderna (NASDAQ:MRNA)
Benzinga· 5 hours agoSubject to necessary permissions from the FDA and CDC, Novavax intends to market this updated...
Best Blue Chip Stocks To Buy in June 2024
GoBankingRates via AOL· 1 day agoBlue chip stocks are among the safest and most secure buys that investors can add to their portfolios. Here are some of the best blue chip stocks to...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 10 hours agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
Dividend stocks can help lower your risk. Many are bargains right now.
MarketWatch via Yahoo Finance· 6 days agoHome Depot Inc. HD — the fund’s 10th largest U.S. stockholding — is another interesting example. If...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Analyzing healthcare M&A trends: Q1 2024 insights - Boston Business Journal
The Business Journals· 19 hours agoHealthcare merger and acquisition activity remained robust in the first quarter of 2024, with 29...